Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 2.06 is 50% below its 5-year average of 4.12, near the low end of its 5-year range (1.55–8.87).
As of the fiscal period ended Tuesday, June 30, 2026. 2.18% below its 12-month average of 2.11.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.06.
QUICK RATIO (ACID-TEST)
2.06
QUICK RATIO (ACID-TEST) AVG TTM
2.11
QUICK RATIO (ACID-TEST) AVG 3Y
2.33
QUICK RATIO (ACID-TEST) AVG 5Y
4.12
QUICK RATIO (ACID-TEST) AVG 10Y
3.99
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.18%
CURRENT VS 3Y AVG
-11.51%
CURRENT VS 5Y AVG
-49.97%
CURRENT VS 10Y AVG
-48.44%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-38.53%
vs the sector median at left
Market Cap
$9.66M
Quick Ratio (Acid-Test)
1.71
TTM Avg
2.19
3Y Avg
2.80
5Y Avg
3.17
Market Cap
$9.92M
Quick Ratio (Acid-Test)
11.22
TTM Avg
10.96
3Y Avg
8.46
5Y Avg
6.93
Market Cap
$9.97M
Quick Ratio (Acid-Test)
0.83
TTM Avg
3.08
3Y Avg
4.37
5Y Avg
4.67
Market Cap
$9.98M
Quick Ratio (Acid-Test)
0.86
TTM Avg
14.33
3Y Avg
8.45
5Y Avg
7.70
Market Cap
$9.17M
Quick Ratio (Acid-Test)
1.47
TTM Avg
3.80
3Y Avg
5.18
5Y Avg
6.13
Market Cap
$10.10M
Quick Ratio (Acid-Test)
1.57
TTM Avg
1.67
3Y Avg
1.44
5Y Avg
1.16
Market Cap
$10.18M
Quick Ratio (Acid-Test)
1.87
TTM Avg
6.83
3Y Avg
7.99
5Y Avg
8.70
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MetaVia Inc. (MTVA) | $9.62M | 2.06 | 2.11 | 2.33 | 4.12 |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | 1.71 | 2.19 | 2.80 | 3.17 |
| Ainos, Inc. (AIMD)vs › | $9.79M | 0.12 | 0.92 | 1.12 | 0.77 |
| Satellos Bioscience Inc. (MSLE)vs › | $9.92M | 11.22 | 10.96 | 8.46 | 6.93 |
| Senti Biosciences, Inc. (SNTI)vs › | $9.97M | 0.83 | 3.08 | 4.37 | 4.67 |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | 0.86 | 14.33 | 8.45 | 7.70 |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.17M | 1.47 | 3.80 | 5.18 | 6.13 |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | 1.57 | 1.67 | 1.44 | 1.16 |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | 1.87 | 6.83 | 7.99 | 8.70 |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.00M | 7.38 | 1.60 | 1.43 | 7.59 |
Quick Ratio
2.06
Excludes inventory
Current Ratio
2.06
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 2.06 |
| 2026-03-31 | 2.73 |
| 2025-12-31 | 1.93 |
| 2025-09-30 | 1.74 |
| 2025-06-30 | 2.08 |
| 2025-03-31 | 1.55 |
| 2024-12-31 | 1.94 |
| 2024-09-30 | 2.41 |
| 2024-06-30 | 2.94 |
| 2024-03-31 | 2.46 |
| 2023-12-31 | 3.78 |
| 2023-09-30 | 5.54 |
| 2023-06-30 | 7.32 |
| 2023-03-31 | 2.87 |
| 2022-12-31 | 2.85 |
| 2022-09-30 | 4.67 |
| 2022-06-30 | 8.07 |
| 2022-03-31 | 8.87 |
| 2021-12-31 | 7.69 |
| 2021-09-30 | 4.13 |
| 2021-06-30 | 8.85 |
| 2021-03-31 | 14.72 |
| 2020-12-31 | 2.89 |
| 2020-09-30 | 3.57 |
| 2020-06-30 | 4.87 |
| 2020-03-31 | 3.03 |
| 2019-12-31 | 6.78 |
| 2019-09-30 | 0.67 |
| 2019-06-30 | 1.95 |
| 2019-03-31 | 3.57 |
| 2018-12-31 | 17.39 |
| 2018-09-30 | 3.26 |
| 2018-06-30 | 4.63 |
| 2018-03-31 | 5.57 |
| 2017-12-31 | 2.97 |
| 2017-09-30 | 4.16 |
| 2017-06-30 | 4.36 |
| 2017-03-31 | 6.57 |
| 2016-12-31 | 6.00 |
| 2016-09-30 | 14.94 |
| 2016-06-30 | 0.47 |
| 2016-03-31 | 0.73 |
| 2015-12-31 | 0.41 |
| 2015-09-30 | 0.00 |
| 2015-06-30 | 0.00 |
| 2015-03-31 | 0.00 |
